Conversely, serum adiponectin concentrations are markedly elevated in conditions such as heart failure and CKD, where increased adiponectin levels have been linked to heightened risk of both all-cause and cardiovascular mortality [14,15]. Here, ADIPOQ is linked to chronic kidney disease.